Narcolepsy Network is a non-profit organization dedicated to individuals with narcolepsy and related sleep disorders. Our mission is to provide services to educate, advocate, support and improve awareness of this neurological sleep disorder.
Latest News & Events
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy
Axsome Therapeutics, Inc. announced that AXS-12 (reboxetine) met the prespecified primary endpoint and significantly reduced the number of cataplexy attacks as compared to placebo in patients with […]
Support Us on #GivingTuesday
On December 3, 2019, Narcolepsy Network will be participating in #GivingTuesday. The Tuesday after Thanksgiving is designed as a day of global giving to celebrate generosity and kindness. Your gift […]
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218
Avadel Pharmaceuticals announced that it has achieved its patient enrollment target of 205 patients in the REST-ON Phase 3 clinical trial for FT218, an investigational, once-nightly formulation […]
Two Clinical Studies on Pitolisant Published
Harmony Biosciences published two clinical studies on WAKIX® (pitolisant). These studies evaluated the long-term safety and efficacy of the medication, as well as its human abuse potential. […]
Tell the FDA that People with Narcolepsy Need Access to CNS Stimulants
The FDA is seeking public input on the development and evaluation of abuse-deterrent formulations of central nervous system stimulants (CNS). While the intent is to deter abuse, […]
What is Narcolepsy?
Narcolepsy is a medical disorder that impacts 1 in approximately 2,000 people in the United States of America. The disease is a sleep disorder, involving irregular patterns in Rapid Eye Movement (REM) Sleep and significant disruptions of the normal sleep/wake cycle. While the cause of narcolepsy is not completely understood, current research points to a combination of genetic and environmental factors that influence the immune system. Read More
